| 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|
| 营业收入(元) | |||
| 成品药销售(元) | 2,651,163,000.42 | 4,720,873,096.18 | 2,167,618,360.11 |
| 技术服务(元) | 14,202,819.97 | 33,506,320.86 | 9,966,889.49 |
| 进出口贸易(元) | 4,611,681.44 | 136,234,186.17 | 80,464,651.74 |
| 原料药及中间体销售(元) | 1,584,849,759.55 | 3,288,328,714.32 | 1,551,540,771.32 |
| 其他主营业务(元) | - | - | 13,558,987.93 |
| 其他(元) | 38,885,435.82 | 86,134,900.47 | 13,558,987.93 |
| 营业成本(元) | |||
| 成品药销售(元) | 791,910,725.41 | 1,176,711,723.37 | 518,646,567.85 |
| 技术服务(元) | 8,975,175.40 | 25,313,753.44 | 7,319,247.90 |
| 进出口贸易(元) | 4,364,392.01 | 123,384,170.81 | 72,716,036.30 |
| 原料药及中间体销售(元) | 892,388,630.40 | 1,738,164,519.56 | 845,546,997.12 |
| 其他主营业务(元) | - | - | 8,794,147.07 |
| 其他(元) | 13,964,427.66 | 46,850,051.84 | 8,794,147.07 |
| 毛利(元) | |||
| 成品药销售(元) | 1,859,252,275.01 | 3,544,161,372.81 | 1,648,971,792.26 |
| 技术服务(元) | 5,227,644.57 | 8,192,567.42 | 2,647,641.59 |
| 进出口贸易(元) | 247,289.43 | 12,850,015.36 | 7,748,615.44 |
| 原料药及中间体销售(元) | 692,461,129.15 | 1,550,164,194.76 | 705,993,774.20 |
| 其他主营业务(元) | - | - | 4,764,840.86 |
| 其他(元) | 24,921,008.16 | 39,284,848.63 | 4,764,840.86 |
| 毛利率(%) | |||
| 成品药销售(%) | 70.13 | 75.07 | 76.07 |
| 技术服务(%) | 36.81 | 24.45 | 26.56 |
| 进出口贸易(%) | 5.36 | 9.43 | 9.63 |
| 原料药及中间体销售(%) | 43.69 | 47.14 | 45.50 |
| 其他主营业务(%) | - | - | 35.14 |
| 其他(%) | 64.09 | 45.61 | 35.14 |
| 收入构成(%) | |||
| 成品药销售(%) | 61.75 | 57.12 | 56.50 |
| 技术服务(%) | 0.33 | 0.41 | 0.26 |
| 进出口贸易(%) | 0.11 | 1.65 | 2.10 |
| 原料药及中间体销售(%) | 36.91 | 39.79 | 40.44 |
| 其他主营业务(%) | - | - | 0.35 |
| 其他(%) | 0.91 | 1.04 | 0.35 |
| 毛利构成(%) | |||
| 成品药销售(%) | 72.01 | 68.76 | 69.43 |
| 技术服务(%) | 0.20 | 0.16 | 0.11 |
| 进出口贸易(%) | 0.01 | 0.25 | 0.33 |
| 原料药及中间体销售(%) | 26.82 | 30.07 | 29.73 |
| 其他主营业务(%) | - | - | 0.20 |
| 其他(%) | 0.97 | 0.76 | 0.20 |